Skip to content
The Race to Develop a Covid-19 Vaccine episode artwork

Sep 15, 2020 45 min

The Race to Develop a Covid-19 Vaccine

from Aspen Ideas to Go Hosted by Aspen Institute

Antibodies, convalescent plasma, gene-based vaccines — you may have heard these terms on the evening news, but what do they mean? How might they help in the battle against Covid-19? As the race to develop a vaccine continues, questions remain about effectiveness, testing, and whether people will actually get the vaccine once it’s on the market. Two medical experts involved in the fight explain the science behind developing effective protection. Judith Aberg is Chief of the Division of Infectious Diseases for Mount Sinai Health System. She’s leading Mount Sinai’s Covid-19 treatment guidelines and the hospital’s clinical trials unit. Florian Krammer is a professor of vaccinology at the Icahn School of Medicine at Mount Sinai. Kenneth L. Davis, president and CEO of Mount Sinai Health System, leads the conversation. Davis is a trustee of the Aspen Institute. As a 501(c)(3) nonprofit organization, the Aspen Institute is nonpartisan and does not endorse, support, or oppose political candidates or parties. Further, the views and opinions of our guests and speakers do not necessarily reflect those of the Aspen Institute.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

The Race to Develop a Covid-19 Vaccine

0:00 45:55

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Aspen Ideas to Go?

This episode is 45 minutes long.

When was this Aspen Ideas to Go episode published?

This episode was published on September 15, 2020.

Can I download this Aspen Ideas to Go episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.